Does TOVORAFENIB Cause Off label use? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Off label use have been filed in association with TOVORAFENIB (OJEMDA). This represents 6.5% of all adverse event reports for TOVORAFENIB.
13
Reports of Off label use with TOVORAFENIB
6.5%
of all TOVORAFENIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Off label use From TOVORAFENIB?
Of the 13 reports, 2 (15.4%) resulted in death, 3 (23.1%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOVORAFENIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TOVORAFENIB Cause?
Accidental underdose (19)
Disease progression (16)
Rash (16)
Fatigue (15)
Headache (12)
Hair colour changes (11)
Blood creatine phosphokinase increased (10)
Acne (8)
Intracranial tumour haemorrhage (8)
Dermatitis acneiform (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TOVORAFENIB Alternatives Have Lower Off label use Risk?
TOVORAFENIB vs TOZINAMERAN
TOVORAFENIB vs TRABECTEDIN
TOVORAFENIB vs TRACLEER
TOVORAFENIB vs TRADJENTA
TOVORAFENIB vs TRALOKINUMAB-LDRM